Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)
DOI: 10.1002/cns.71118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 06.10.2026. Verfasst von Qi Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Platelet Factor 4. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Background
As population aging accelerates worldwide, the prevalence and burden of neurodegenerative diseases (NDs) continue to rise, underscoring the urgent need to identify key molecular mechanisms driving disease progression and novel therapeutic targets. Chronic neuroinflammation is a hallmark of multiple NDs, including Alzheimer's disease and Parkinson's disease. Platelet factor 4 (PF4) is a chemokine primarily released by activated platelets and has traditionally been investigated for its roles in hemostasis, thrombosis, and peripheral inflammation.
Results
Growing evidence has implicated PF4 in the pathogenesis of NDs. Altered PF4 expression has been observed across multiple NDs. As a central player at the intersection of the nervous, immune, and vascular systems, PF4 modulates inflammation, vascular homeostasis, and neuronal survival, all of which are critical in the pathogenesis of NDs. Dissecting the cell‐type specific and temporally dynamic roles of PF4 across diverse disease contexts is essential for elucidating its contribution to neurodegenerative processes and disease progression.
Conclusion
This review highlights PF4 as a potential mechanistic mediator in NDs and discusses its promise as both a biomarker and a therapeutic target. Further elucidation of PF4 signaling pathways may provide new insights into disease mechanisms and uncover novel opportunities for targeted interventions in NDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania, USA.
- Department of Neurology, Westchester Medical Center New York Medical College, Valhalla, New York, USA.
ORCID-Profile: Qi Tian, Yanji Tong, Xiaoming Hu
Förderung
- NIH HHS
- NINDS NIH HHS
- U.S. Department of Veterans Affairs
- BLRD VA
- National Institutes of Health
Zitieren
APA
Tian, Q., Tong, Y., Yu, F., & Hu, X. (2026). Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71118
Vancouver
Tian Q, Tong Y, Yu F, Hu X. Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71118
BibTeX
@article{Tian2026,
author = {Tian, Qi and Tong, Yanji and Yu, Fang and Hu, Xiaoming},
title = {Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {10},
doi = {10.1002/cns.71118}
}
EUVIMED